415 related articles for article (PubMed ID: 18364368)
1. Platelet activation in clinical haemodialysis: LMWH as a major contributor to bio-incompatibility?
Gritters M; Borgdorff P; Grooteman MP; Schoorl M; Schoorl M; Bartels PC; Tangelder GJ; Nubé MJ
Nephrol Dial Transplant; 2008 Sep; 23(9):2911-7. PubMed ID: 18364368
[TBL] [Abstract][Full Text] [Related]
2. The role of the extracorporeal circuit in the trapping and degranulation of platelets.
Gritters-van den Oever M; Schoorl M; Schoorl M; Bartels PC; Grooteman MP; Nubé MJ
Blood Purif; 2009; 28(3):253-9. PubMed ID: 19684392
[TBL] [Abstract][Full Text] [Related]
3. Post-dilution haemodiafiltration and low-flux haemodialysis have dissimilar effects on platelets: a side study of CONTRAST.
Gritters-van den Oever M; Grooteman MP; Bartels PC; Blankestijn PJ; Bots ML; van den Dorpel MA; Schoorl M; Schoorl M; Ter Wee PM; Nubé MJ
Nephrol Dial Transplant; 2009 Nov; 24(11):3461-8. PubMed ID: 19561150
[TBL] [Abstract][Full Text] [Related]
4. Citrate anticoagulation abolishes degranulation of polymorphonuclear cells and platelets and reduces oxidative stress during haemodialysis.
Gritters M; Grooteman MP; Schoorl M; Schoorl M; Bartels PC; Scheffer PG; Teerlink T; Schalkwijk CG; Spreeuwenberg M; Nubé MJ
Nephrol Dial Transplant; 2006 Jan; 21(1):153-9. PubMed ID: 16144857
[TBL] [Abstract][Full Text] [Related]
5. The AN69 ST haemodialysis membrane under conditions of two different extracorporeal circuit rinse protocols a comparison of thrombogenicity parameters.
Richtrova P; Opatrny K; Vit L; Sefrna F; Perlik R
Nephrol Dial Transplant; 2007 Oct; 22(10):2978-84. PubMed ID: 17597089
[TBL] [Abstract][Full Text] [Related]
6. Heparin-induced thrombocytopenia: a stoichiometry-based model to explain the differing immunogenicities of unfractionated heparin, low-molecular-weight heparin, and fondaparinux in different clinical settings.
Greinacher A; Alban S; Omer-Adam MA; Weitschies W; Warkentin TE
Thromb Res; 2008; 122(2):211-20. PubMed ID: 18262226
[TBL] [Abstract][Full Text] [Related]
7. [Prevention of thrombogenesis in the extracorporeal circuit of hemodialysis with a low molecular heparin: standardization of the dosage with a better hemorrhagic risk/effectiveness ratio].
Barata JD; Oliveira C; Bruges M; Gusmão L; Santana A; Ponce P; Simões J; Freire I; Crespo F; da Silva AN
Acta Med Port; 1992 Feb; 5(2):65-70. PubMed ID: 1317657
[TBL] [Abstract][Full Text] [Related]
8. Reduction in platelet activation by citrate anticoagulation does not prevent intradialytic hemodynamic instability.
Gritters M; Borgdorff P; Grooteman MP; Schoorl M; Schoorl M; Bartels PC; Tangelder GJ; Nubé MJ
Nephron Clin Pract; 2007; 106(1):c9-16. PubMed ID: 17347579
[TBL] [Abstract][Full Text] [Related]
9. Platelet depletion, platelet activation and coagulation during treatment with hemodialysis.
Schoorl M; Schoorl M; Nubé MJ; Bartels PC
Scand J Clin Lab Invest; 2011 May; 71(3):240-7. PubMed ID: 21303224
[TBL] [Abstract][Full Text] [Related]
10. Increased releasability of platelet products and reduced heparin-induced platelet factor 4 release from endothelial cells in bronchial asthma.
Yasuba H; Chihara J; Kino T; Satake N; Oshima S
J Lipid Mediat; 1991; 4(1):5-21. PubMed ID: 1832572
[TBL] [Abstract][Full Text] [Related]
11. Effects of standard unfractionated and low-molecular-weight heparins on platelets of patients undergoing total hip replacement surgery.
Aulmann M; Kwasniki S; Böttiger BW; Meeder PJ
Beitr Infusionsther Transfusionsmed; 1997; 34():242-7. PubMed ID: 9356680
[TBL] [Abstract][Full Text] [Related]
12. Anticoagulant-free Genius haemodialysis using low molecular weight heparin-coated circuits.
Frank RD; Müller U; Lanzmich R; Groeger C; Floege J
Nephrol Dial Transplant; 2006 Apr; 21(4):1013-8. PubMed ID: 16326745
[TBL] [Abstract][Full Text] [Related]
13. Platelet anaesthesia during extracorporeal circulation: differential effects of GP IIb/IIIa blockers on platelet activation marker P-selectin expression at hypothermia.
Straub A; Schiebold D; Wendel HP; Azevedo R; Dietz K; Ziemer G
Thromb Res; 2008; 122(3):383-9. PubMed ID: 18304613
[TBL] [Abstract][Full Text] [Related]
14. Patient characteristics rather than the type of dialyser predict the variability of endothelial derived surface molecules in chronic haemodialysis patients.
Grooteman MP; Gritters M; Wauters IM; Schalkwijk CG; Stam F; Twisk J; Ter Wee PM; Nubé MJ
Nephrol Dial Transplant; 2005 Dec; 20(12):2751-8. PubMed ID: 16188898
[TBL] [Abstract][Full Text] [Related]
15. Activation of coagulation during hemodialysis: effect of blood lines alone and whole extracorporeal circuit.
Lucchi L; Ligabue G; Marietta M; Delnevo A; Malagoli M; Perrone S; Stipo L; Grandi F; Albertazzi A
Artif Organs; 2006 Feb; 30(2):106-10. PubMed ID: 16433843
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of low-molecular-weight heparin reversal by platelet factor 4.
Fiore MM; Mackie IM
Thromb Res; 2009 May; 124(1):149-55. PubMed ID: 19195682
[TBL] [Abstract][Full Text] [Related]
17. [Some parameters of platelet activation in patients with uremia before and after hemodialysis (HD)].
Dymicka-Piekarska V; Matowicka-Karna J; Mantur M; Kemona H; Piszka J
Przegl Lek; 2002; 59(12):980-3. PubMed ID: 12731371
[TBL] [Abstract][Full Text] [Related]
18. Plasma cytokine and P-selectin levels in advanced malignancy: prognostic value and impact of low-molecular weight heparin administration.
Di Nisio M; Niers TM; Reitsma PH; Buller HR
Cancer; 2005 Nov; 104(10):2275-81. PubMed ID: 16216004
[TBL] [Abstract][Full Text] [Related]
19. Immunoassay of human platelet factor 4(PF4, antiheparin factor) by radial immunodiffusion.
Niewiarowski S; Lowery CT; Hawiger J; Millman M; Timmons S
J Lab Clin Med; 1976 Apr; 87(4):720-33. PubMed ID: 818325
[TBL] [Abstract][Full Text] [Related]
20. Does renal carcinoma affect the expression of P-selectin on platelets?
Mantur M; Kemona H; Pietruczuk M; Wasiluk A
Neoplasma; 2002; 49(4):243-5. PubMed ID: 12382022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
